Why VistaGen Therapeutics Stock Is Soaring Today
Shares of VistaGen Therapeutics (NASDAQ: VTGN) were soaring 22.1% as of 11:27 a.m. EST on Thursday. The big jump came after Jefferies analyst Andrew Tsai initiated coverage on the stock with a buy recommendation. Tsai also set a one-year price target of $6, nearly three times the price of VistaGen's shares at the market close on Wednesday.
Wall Street analysts aren't always right with their recommendations and price targets. But it's a good idea to at least understand why they're bullish about a stock.
Image source: Getty Images.
Source Fool.com
